NFKB1 and breast cancer: Meanwhile, S100A8/S100A9 from BC cells binds to receptor for advanced glycation end products on MDSCs and can activate the mitogen-activated protein kinase and nuclear factor kappa-B (NF-κB) signaling pathways in tumor cells to stimulate tumor invasion (Sinha et al., 2008).